金吾财讯 | 艾美疫苗(06660)早盘股价强势，截至发稿，报8.18港元，涨4.47%，成交额4349.4万港元。消息面上，公司公布，迭代工艺高效价人二倍体狂犬疫苗已于近日向国家药品监督管理局药品审评中心申报临床。目前市场上的人二倍体狂犬疫苗价格比Vero细胞狂犬疫苗高3至5倍。该集团指已具备该产品规模化生产能力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.